Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9986, pp. 2465 - 2476
Summary Background It is unclear whether radial compared with femoral access improves outcomes in unselected patients with acute coronary syndromes undergoing...
Internal Medicine | LEARNING-CURVE | SITE | MEDICINE, GENERAL & INTERNAL | ANGIOGRAPHY | METAANALYSIS | ACUTE MYOCARDIAL-INFARCTION | OUTCOMES | ST-SEGMENT ELEVATION | CARDIOVASCULAR DATA REGISTRY | INTERVENTION | ASSOCIATION | Catheterization, Peripheral - methods | Blood Loss, Surgical - prevention & control | Humans | Acute Coronary Syndrome - mortality | Male | Survival Rate | Treatment Outcome | Cause of Death | Coronary Angiography | Radial Artery | Percutaneous Coronary Intervention - methods | Acute Coronary Syndrome - surgery | Female | Femoral Artery | Aged | Blood Loss, Surgical - mortality | Catheterization, Peripheral - adverse effects | Clinical trials | Care and treatment | Coronary heart disease | Cardiac patients | Heart attacks | Acute coronary syndromes | Cardiology | Mortality | Veins & arteries
Internal Medicine | LEARNING-CURVE | SITE | MEDICINE, GENERAL & INTERNAL | ANGIOGRAPHY | METAANALYSIS | ACUTE MYOCARDIAL-INFARCTION | OUTCOMES | ST-SEGMENT ELEVATION | CARDIOVASCULAR DATA REGISTRY | INTERVENTION | ASSOCIATION | Catheterization, Peripheral - methods | Blood Loss, Surgical - prevention & control | Humans | Acute Coronary Syndrome - mortality | Male | Survival Rate | Treatment Outcome | Cause of Death | Coronary Angiography | Radial Artery | Percutaneous Coronary Intervention - methods | Acute Coronary Syndrome - surgery | Female | Femoral Artery | Aged | Blood Loss, Surgical - mortality | Catheterization, Peripheral - adverse effects | Clinical trials | Care and treatment | Coronary heart disease | Cardiac patients | Heart attacks | Acute coronary syndromes | Cardiology | Mortality | Veins & arteries
Journal Article
2.
Full Text
Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RADMatrix Trial
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017
Abstract Background It remains unclear whether radial increases the risk of operator or patient radiation exposure when performed by expert operators...
Cardiovascular | Internal Medicine
Cardiovascular | Internal Medicine
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 21, pp. 2592 - 2603
Abstract Background It remains unclear whether radial access (RA), compared with femoral access (FA), mitigates the risk of acute kidney injury (AKI)....
Cardiovascular | Internal Medicine | coronary intervention | creatinine | bleeding | estimated glomerular filtration rate | ST-segment elevation
Cardiovascular | Internal Medicine | coronary intervention | creatinine | bleeding | estimated glomerular filtration rate | ST-segment elevation
Journal Article
Journal of Electrocardiology, ISSN 0022-0736, 2019, Volume 57, pp. 44 - 54
AbstractBackgroundThe twelve‑lead electrocardiogram (ECG) has become an essential tool for the diagnosis, risk stratification, and management of patients with...
Cardiovascular | Myocardial infarction | ECG | Atrial infarction | Percutaneous coronary intervention | Acute coronary syndromes | Radial access
Cardiovascular | Myocardial infarction | ECG | Atrial infarction | Percutaneous coronary intervention | Acute coronary syndromes | Radial access
Journal Article
Heart Rhythm, ISSN 1547-5271, 2011, Volume 8, Issue 1, pp. 8 - 15
Background Nonirrigated magnetic ablation may result in potential char, ineffective lesions, and longer procedure times. Objective This study sought to report...
Cardiovascular | Irrigated radiofrequency ablation | Atrial fibrillation | Catheter ablation | CARDIAC & CARDIOVASCULAR SYSTEMS | SAFETY | Irrigated radio-frequency ablation | PULMONARY-VEIN ABLATION | ATRIAL-FIBRILLATION | RADIOFREQUENCY ABLATION | Recurrence | Prospective Studies | Humans | Middle Aged | Male | Treatment Outcome | Anti-Arrhythmia Agents - therapeutic use | Magnetics | Atrial Fibrillation - surgery | Equipment Design | Catheters | Catheter Ablation - methods | Atrial Fibrillation - mortality | Catheter Ablation - instrumentation | Female | Aged
Cardiovascular | Irrigated radiofrequency ablation | Atrial fibrillation | Catheter ablation | CARDIAC & CARDIOVASCULAR SYSTEMS | SAFETY | Irrigated radio-frequency ablation | PULMONARY-VEIN ABLATION | ATRIAL-FIBRILLATION | RADIOFREQUENCY ABLATION | Recurrence | Prospective Studies | Humans | Middle Aged | Male | Treatment Outcome | Anti-Arrhythmia Agents - therapeutic use | Magnetics | Atrial Fibrillation - surgery | Equipment Design | Catheters | Catheter Ablation - methods | Atrial Fibrillation - mortality | Catheter Ablation - instrumentation | Female | Aged
Journal Article
The Lancet, ISSN 0140-6736, 09/2018, Volume 392, Issue 10150, pp. 835 - 848
The Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox (MATRIX) programme was designed to assess the...
2017 ESC | SITE | ANGIOGRAPHY | METAANALYSIS | MONOTHERAPY | PCI | ACUTE MYOCARDIAL-INFARCTION | INTERVENTION | ARTERY-DISEASE | MEDICINE, GENERAL & INTERNAL | Perioperative Care | Anticoagulants - administration & dosage | Humans | Middle Aged | Heparin - administration & dosage | Male | Antithrombins - administration & dosage | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Acute Coronary Syndrome - complications | Radial Artery | Percutaneous Coronary Intervention - methods | Female | Femoral Artery | Myocardial Infarction - etiology | Mortality | Peptide Fragments - administration & dosage | Acute Coronary Syndrome - diagnostic imaging | Anticoagulants - adverse effects | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Coronary Angiography | Stroke - etiology | Antithrombins - adverse effects | Hirudins - adverse effects | Acute Coronary Syndrome - surgery | Aged | Peptide Fragments - adverse effects | Hemorrhage - chemically induced | Prosthesis Failure - etiology | Stents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Anticoagulants (Medicine) | Coronary heart disease | Analysis | Cardiac patients | Intervention | Myocardial infarction | Short term | Surgical implants | Femur | Heart attacks | Angiography | Medical services | Clinical trials | Antithrombin | Matrix methods | Bleeding | Infusion | Elevation | Randomization | Motivation | Mathematical analysis | Calcium-binding protein | Implants | Cardiology | Thromboembolism | Stents | Cerebral infarction | Stroke | Medical imaging | Coronary artery | Glycoprotein | Glycoproteins | Angina pectoris | Patients | Thrombosis | Troponin | Inhibitors | Clopidogrel | Infarction | Heparin | Acute coronary syndromes | Kardiologi | Cardiac and Cardiovascular Systems
2017 ESC | SITE | ANGIOGRAPHY | METAANALYSIS | MONOTHERAPY | PCI | ACUTE MYOCARDIAL-INFARCTION | INTERVENTION | ARTERY-DISEASE | MEDICINE, GENERAL & INTERNAL | Perioperative Care | Anticoagulants - administration & dosage | Humans | Middle Aged | Heparin - administration & dosage | Male | Antithrombins - administration & dosage | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Acute Coronary Syndrome - complications | Radial Artery | Percutaneous Coronary Intervention - methods | Female | Femoral Artery | Myocardial Infarction - etiology | Mortality | Peptide Fragments - administration & dosage | Acute Coronary Syndrome - diagnostic imaging | Anticoagulants - adverse effects | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Coronary Angiography | Stroke - etiology | Antithrombins - adverse effects | Hirudins - adverse effects | Acute Coronary Syndrome - surgery | Aged | Peptide Fragments - adverse effects | Hemorrhage - chemically induced | Prosthesis Failure - etiology | Stents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Anticoagulants (Medicine) | Coronary heart disease | Analysis | Cardiac patients | Intervention | Myocardial infarction | Short term | Surgical implants | Femur | Heart attacks | Angiography | Medical services | Clinical trials | Antithrombin | Matrix methods | Bleeding | Infusion | Elevation | Randomization | Motivation | Mathematical analysis | Calcium-binding protein | Implants | Cardiology | Thromboembolism | Stents | Cerebral infarction | Stroke | Medical imaging | Coronary artery | Glycoprotein | Glycoproteins | Angina pectoris | Patients | Thrombosis | Troponin | Inhibitors | Clopidogrel | Infarction | Heparin | Acute coronary syndromes | Kardiologi | Cardiac and Cardiovascular Systems
Journal Article
American Heart Journal, ISSN 0002-8703, 03/2019, Volume 209, pp. 97 - 105
The optimal duration of antiplatelet therapy in high–bleeding risk (HBR) patients with coronary artery disease treated with newer-generation drug-eluting...
SYSTEM | CARDIAC & CARDIOVASCULAR SYSTEMS | DUAL-ANTIPLATELET THERAPY | CORONARY | CLINICAL-EVALUATION | VALIDATION | BARE-METAL STENT | DURATION | FOCUSED UPDATE | Polymer industry | Therapy | Surgical implants | Heart attacks | Sirolimus | Cardiovascular disease | Drug delivery | Drug development | Coatings | Bleeding | Biomedical materials | Randomization | Implants | Biocompatibility | Nonsteroidal anti-inflammatory drugs | Polymers | Cardiology | Heart diseases | Stents | Anticoagulants | Stroke | Aspirin | Anemia | Coronary artery | Health risks | Implantation | Coronary artery disease | Patients | Studies | Composite materials | Polymer coatings | Coating | Risk management | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
SYSTEM | CARDIAC & CARDIOVASCULAR SYSTEMS | DUAL-ANTIPLATELET THERAPY | CORONARY | CLINICAL-EVALUATION | VALIDATION | BARE-METAL STENT | DURATION | FOCUSED UPDATE | Polymer industry | Therapy | Surgical implants | Heart attacks | Sirolimus | Cardiovascular disease | Drug delivery | Drug development | Coatings | Bleeding | Biomedical materials | Randomization | Implants | Biocompatibility | Nonsteroidal anti-inflammatory drugs | Polymers | Cardiology | Heart diseases | Stents | Anticoagulants | Stroke | Aspirin | Anemia | Coronary artery | Health risks | Implantation | Coronary artery disease | Patients | Studies | Composite materials | Polymer coatings | Coating | Risk management | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 11/2015, Volume 86, Issue 5, pp. 950 - 957
Acute kidney injury (AKI) is an important complication of both diagnostic cardiac catheterization and percutaneous coronary intervention (PCI). A large body of...
contrast‐induced nephropathy | transradial intervention | percutaneous coronary intervention | acute kidney injury | acute coronary syndromes | Percutaneous coronary intervention | Acute coronary syndromes | Acute kidney injury | Contrast-induced nephropathy | Transradial intervention | CROSS BLUE-SHIELD | CARDIAC & CARDIOVASCULAR SYSTEMS | CHOLESTEROL EMBOLIZATION | FEMORAL APPROACH | RADIAL APPROACH | contrast-induced nephropathy | ACUTE MYOCARDIAL-INFARCTION | CARDIAC-CATHETERIZATION | MICHIGAN CARDIOVASCULAR CONSORTIUM | ST-SEGMENT ELEVATION | CLINICAL-OUTCOMES | Catheterization, Peripheral - methods | Prospective Studies | Percutaneous Coronary Intervention - mortality | Humans | Clinical Protocols | Acute Coronary Syndrome - mortality | Hemorrhage - mortality | Catheterization, Peripheral - mortality | Antithrombins - administration & dosage | Coronary Angiography - adverse effects | Hemorrhage - prevention & control | Recombinant Proteins - adverse effects | Hirudins - administration & dosage | Incidence | Contrast Media - adverse effects | Time Factors | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Acute Kidney Injury - etiology | Catheterization, Peripheral - adverse effects | Peptide Fragments - administration & dosage | Risk Factors | Acute Coronary Syndrome - diagnostic imaging | Punctures | Treatment Outcome | Acute Kidney Injury - prevention & control | Recombinant Proteins - administration & dosage | Hemorrhage - diagnosis | Acute Kidney Injury - mortality | Antithrombins - adverse effects | Hirudins - adverse effects | Acute Kidney Injury - diagnosis | Acute Coronary Syndrome - therapy | Peptide Fragments - adverse effects | Percutaneous Coronary Intervention - adverse effects | Research Design | Radial Artery - diagnostic imaging | Transluminal angioplasty | Cardiac patients | Contrast media
contrast‐induced nephropathy | transradial intervention | percutaneous coronary intervention | acute kidney injury | acute coronary syndromes | Percutaneous coronary intervention | Acute coronary syndromes | Acute kidney injury | Contrast-induced nephropathy | Transradial intervention | CROSS BLUE-SHIELD | CARDIAC & CARDIOVASCULAR SYSTEMS | CHOLESTEROL EMBOLIZATION | FEMORAL APPROACH | RADIAL APPROACH | contrast-induced nephropathy | ACUTE MYOCARDIAL-INFARCTION | CARDIAC-CATHETERIZATION | MICHIGAN CARDIOVASCULAR CONSORTIUM | ST-SEGMENT ELEVATION | CLINICAL-OUTCOMES | Catheterization, Peripheral - methods | Prospective Studies | Percutaneous Coronary Intervention - mortality | Humans | Clinical Protocols | Acute Coronary Syndrome - mortality | Hemorrhage - mortality | Catheterization, Peripheral - mortality | Antithrombins - administration & dosage | Coronary Angiography - adverse effects | Hemorrhage - prevention & control | Recombinant Proteins - adverse effects | Hirudins - administration & dosage | Incidence | Contrast Media - adverse effects | Time Factors | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Acute Kidney Injury - etiology | Catheterization, Peripheral - adverse effects | Peptide Fragments - administration & dosage | Risk Factors | Acute Coronary Syndrome - diagnostic imaging | Punctures | Treatment Outcome | Acute Kidney Injury - prevention & control | Recombinant Proteins - administration & dosage | Hemorrhage - diagnosis | Acute Kidney Injury - mortality | Antithrombins - adverse effects | Hirudins - adverse effects | Acute Kidney Injury - diagnosis | Acute Coronary Syndrome - therapy | Peptide Fragments - adverse effects | Percutaneous Coronary Intervention - adverse effects | Research Design | Radial Artery - diagnostic imaging | Transluminal angioplasty | Cardiac patients | Contrast media
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 08/2018, Volume 11, Issue 16, pp. 1576 - 1586
The study sought to assess whether treatment with ticagrelor, as compared with prasugrel and clopidogrel, improves endothelium-dependent dilation throughout...
adenosine | endothelial function | P2Y12 inhibitors | prasugrel | ticagrelor
adenosine | endothelial function | P2Y12 inhibitors | prasugrel | ticagrelor
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 12/2016, Volume 88, Issue 7, pp. 1188 - 1188
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.